Videos

7. Siemens Healthineers

7. Siemens Healthineers

Highlights from one of the number seven spot holders of MPO's Top 30 Global Medical Device Companies report.

By Sean Fenske, Editor-in-Chief09.11.19
For years, there has been speculation regarding a number of conglomerates that would see the company spin out its medical device business. Rumors have circulated around Johnson & Johnson, GE Healthcare, Alcon (which was finally launched by parent Novartis in April), among others. In 2018, Siemens took the first steps toward creating a new, independent entity comprised of its Healthineers unit.
 
On March 16, 2018, shares of Siemens Healthineers (representing a 15 percent stake in the company) debuted on the Frankfurt stock exchange. The shares were issued at a price of 28 euros (which immediately rose 7 percent during trading that same day)—a “discounted price” cited by some market participants as a way for Siemens to promote interest. The asking price was down from the figure initial estimates had it at when the IPO announcement was made in November of the year prior. At that time, speculation put the company’s value at 40 billion euros. Ultimately, however, Healthineers’ equity was valued at 28 billion euros for the IPO debut—still the world’s largest in the healthcare sector to date, according to Siemens Chairman Michael Sen.
 
For more information about Siemens Healthineers, check out the company’s full Top 30 report here!
Related Searches:
Suggested For You

Related Breaking News

    Loading, Please Wait..